SCHEMBL5041566

SCHEMBL5041566

COC(C(=O)O)c1cc(Br)ccc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
APLNR P35414 2/20 0.40
PPARG P37231 2/20 0.39
PPARA Q07869 2/20 0.39
DGAT1 O75907 1/20 0.38
GAA P10253 1/20 0.37
BMP1 P13497 1/20 0.36
FPR2 P25090 1/20 0.36
KDM4E B2RXH2 2/20 0.35
LDHA P00338 1/20 0.35
GLA P06280 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP7 P09237 1/20 0.34
MMP9 P14780 1/20 0.34
MMP13 P45452 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041250 0.87 ALDH1A1 (0.53) ALDH1A1L3MBTL1APLNRPPARGPPARA
SCHEMBL5041933 0.82 ALDH1A1 (0.38) ALDH1A1L3MBTL1PPARGPPARAGAA
SCHEMBL2349189 0.81 AKR1C3 (0.43) KDM4ELDHA
SCHEMBL5041168 0.78 IDO1 (0.46) ALDH1A1PPARGPPARAKDM4E
SCHEMBL3172075 0.77 KDM4E (0.50) ALDH1A1L3MBTL1KDM4EGLA
SCHEMBL5037418 0.76 ALDH1A1 (0.51) ALDH1A1L3MBTL1GAAKDM4ELMNA
SCHEMBL6818451 0.76 CES2 (0.45) ALDH1A1L3MBTL1DGAT1GAAFPR2
SCHEMBL17724548 0.76 ALDH1A1 (0.51) ALDH1A1L3MBTL1GAAKDM4ELMNA
SCHEMBL24223271 0.76 FFAR4 (0.41)
SCHEMBL17847415 0.75 DGAT1 (0.44) ALDH1A1APLNRDGAT1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 ALDH1A1 519/4885L3MBTL1 1475/4885APLNR 736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.